Largest study on infant-type hemispheric glioma reports factors to guide treatment approaches

Clinician-scientists at St. Jude Children's Research Hospital and collaborators have conducted the largest study of ...

Bacteria Found Inside Brain Tumors May Influence Tumor Behavior

Researchers have uncovered unexpected traces of bacteria in brain tumors, opening a new dimension in our understanding of ...

Actinium Pharmaceuticals, Inc. to Highlight ATNM-400 Data in Hormone-Resistant and HER2-Resistant Breast Cancer at the 2025 San Antonio Breast Cancer Symposium, Expanding Pan ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or the "Company"), a leader in the development of differentiated targeted radiotherapies, announced today that new preclinical data for ...

Verrica Pharmaceuticals Presents New Data on VP-315 from its Phase 2 Clinical Trial in Basal Cell Carcinoma at the 40th Society for Immunotherapy of Cancer Annual Meeting

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, increasing cytotoxic ...
The Print

Dr. Mohana Rao Unveils India’s Largest 1008-Case IONM Study at SIONCON 2025

In what experts are calling one of the most substantial contributions to neurosurgical safety research in recent years, Dr ...
HealthDay on MSN

Multicancer Early Detection Test Reduces Late-Stage Diagnoses

(HealthDay News) — Multicancer early detection (MCED) tests can increase earlier-stage diagnoses and reduce late-stage diagnoses, according to a study published online Nov. 10 in Cancer.